|
1. Mills S, Bone K. Principles and practice of phytotherapy. Modern herbal medicine: Churchill Livingstone; 2000. Dragon DC, Rennie RP. The ecology of anthrax spores: tough but not invincible. Can Vet J. 1995;36(5):295-301. PMID: 7773917 2. Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, Mock M, et al. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl Environ Microbiol. 2000;66(6):2627-30. PMID: 10831447 [ DOI:10.1128/AEM.66.6.2627-2630.2000] 3. Schuch R, Nelson D, Fischetti VA. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature. 2002;418(6900):884-9. [ DOI:10.1038/nature01026] 4. Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med. 2001;345(22):1607-10. PMID: 11704685 [ DOI:10.1056/NEJMoa012948] 5. Jassim SA, Limoges RG. Bacteriophage Biodefense. Bacteriophages: Practical Applications for Nature's Biocontrol: Springer; 2017. p. 193-222.
_7 [ DOI:10.1007/978-3-319-54051-1] 6. Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases: Elsevier Health Sciences; 2014. 7. Turnbull PC, Organization WH. Guidelines for the surveillance and control of anthrax in humans and animals: World Health Organization, Department of Communicable Diseases Surveillance and Response; 1998. 8. Brachman PS, Abrutyn E. Bacterial infections of humans: epidemiology and control: Springer; 2009. [ DOI:10.1007/978-0-387-09843-2] [ PMID] [ PMCID] 9. Turnbull P. Anthrax in humans and animals: World Health Organization; 2008. 10. Harrison WA. Electronic structure and the properties of solids: the physics of the chemical bond: Courier Corporation; 2012. 11. Malani PN. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Springer2010. 2067-71 p. 12. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287(17):2236-52. PMID: 11980524 [ DOI:10.1001/jama.287.17.2236] [ PMID] 13. De Cauwer H, Somville F, Joillet M. Neurological aspects of chemical and biological terrorism: guidelines for neurologists. Acta Neurol Belg. 2017;117(3):603-11. PMID: 28343251 [ DOI:10.1007/s13760-017-0774-y] 14. Ambrose EA. Botulinum Neurotoxin, Tetanus Toxin, and Anthrax Lethal Factor Countermeasures. Enzymes Microorgan. 2017:47-67. 15. Ózsvári L, Kasza G, Lakner Z. Historical and economic aspects of bioterrorism. 2017. [ DOI:10.18515/dBEM.M2017.n01.ch18] 16. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8(10):1019-28. PMID: 12396909 [ DOI:10.3201/eid0810.020353] 17. Paar SN. Future Terrorism in the United States: Implications for the USAF: AIR UNIVERSITY; 1999. 18. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7(6):933-44. PMID: 11747719 [ DOI:10.3201/eid0706.010604] 19. Ranjbar R. Identification and management of biological threats in the field of humaN. Univ Imam Hussein. 2014;1(1):507. 20. Zaric GS, Bravata DM, Cleophas Holty JE, McDonald KM, Owens DK, Brandeau ML. Modeling the logistics of response to anthrax bioterrorism. Med Decis Making. 2008;28(3):332-50. PMID: 18349432 [ DOI:10.1177/0272989X07312721] 21. Karami A. Analysis of recent events anthrax bioterrorism. J Mil Med. 2002;4(1):23-30. 22. Li Y, Yin W, Hugh-Jones M, Wang L, Mu D, Ren X, et al. Epidemiology of Human Anthrax in China, 1955-2014. Emerg Infect Dis. 2017;23(1):14-21. PMID: 27983489 [ DOI:10.3201/eid2301.150947] 23. Gordon SM. The threat of bioterrorism: a reason to learn more about anthrax and smallpox. Cleve Clin J Med. 1999;66(10):592-5, 9-600. PMID: 10598363 24. Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, et al. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes. Vaccine. 2017;35(44):6030-40. PMID: 28342664 [ DOI:10.1016/j.vaccine.2017.03.033] 25. Beatty ME, Ashford DA, Griffin PM, Tauxe RV, Sobel J. Gastrointestinal anthrax: review of the literature. Arch Intern Med. 2003;163(20):2527-31. PMID: 14609791 [ DOI:10.1001/archinte.163.20.2527] 26. Mardani M. Cutaneous anthrax study on 50 cases of patients admitted to the Hospital, Ayatollah Kashani. J Mazandaran Univ Med Sci. 2000;10(29):23-9. 27. Esmaeli H, Zarei t, Hamidian Z, GHazinafiseh A, Fatami M. Cutaneous anthrax epidemic outbreak reported in the villages of city functions Esfaraien North Khorasan Province. J nfect Dis Tropical Med. 2010;15(48):23. 28. Habibian R. A case of bacteremia and meningoencephalitis Anthrax. J Univ Shahrkord. 2002;1(4):51. 29. Eisazadeh S, Mehranfar J. Afghan migrants impact on the unemployment rate in Iran. Q J Econ Shahid Beheshti Univ. 2010;4(1):129. 30. Garofolo G, Ciammaruconi A, Fasanella A, Scasciamacchia S, Adone R, Pittiglio V, et al. SNR analysis: molecular investigation of an anthrax epidemic. BMC Vet Res. 2010;6(1):11. PMID: 20187980 [ DOI:10.1186/1746-6148-6-11] 31. Majid F, Khakshor A, Gholampoor A, editors. The relationship between the prevention of anthrax in livestock and its incidence in humans. Conference zoonotic diseases; 2013.
|
